Table 3.
28-day mortality effect estimates from network meta-analysis.
| Norepinephrine | Dopamine | Epinephrine | Vasopressins | Norepinephrine and epinephrine | Norepinephrine and dobutamine | |
|---|---|---|---|---|---|---|
| Norepinephrine | – | OR 1.2; 95% CI 0.97 to 1.5 | OR 0.69; 95% CI 0.34 to 1.42 | OR 0.82; 95% CI 0.66 to 1.03 | OR 0.63; 95% CI 0.17 to 2.37 | OR 0.55; 95% CI 0.23 to 1.27 |
| Dopamine | – | – | OR 0.58; 95% CI 0.27 to 1.22 | OR 0.68; 95% CI 0.5 to 0.94 | OR 0.52; 95% CI 0.14 to 2 | OR 0.45; 95% CI 0.19 to 1.09 |
| Epinephrine | – | – | – | OR 1.19; 95% CI 0.56 to 2.52 | OR 0.91; 95% CI 0.2 to 4.1 | OR 0.79; 95% CI 0.26 to 2.39 |
| Vasopressins | – | – | – | – | OR 0.76; 95% CI 0.2 to 2.93 | OR 0.66; 95% CI 0.28 to 1.59 |
| Norepinephrine and epinephrine | – | – | – | – | – | OR 0.87; 95% CI 0.18 to 4.21 |
| Norepinephrine and dobutamine | – | – | – | – | – | – |
Note: The odds ratio represents the odds of mortality in the agent at the top of the table relative to the agent in the first column of the table.
CI, 95% credible intervals (equivalent to 95% confidence intervals); OR: odds ratio.